Sleep and Vigilance

, Volume 2, Issue 2, pp 135–140 | Cite as

Systemic Comorbidities in Patients with Obstructive Sleep Apnea Syndrome

  • Pınar MutluEmail author
  • Nihal Arzu Mirici
Original Article



This study aims to evaluate systemic comorbidities in patients diagnosed with obstructive sleep apnea syndrome (OSAS).

Materials and Methods

The study included 90 patients who were admitted to the sleep laboratory to undergo standard polysomnography (PSG) and diagnosed with OSAS between January 2016 and January 2017. The data of the patients were retrieved from the records and retrospectively reviewed. Data including age and sex, height, weight, medical history, comorbidities, and drug use were recorded. All data related to the comorbidities including diabetes mellitus (DM), endocrinological disorders such as thyroid diseases, chronic respiratory conditions, and cardiovascular and neurological diseases were evaluated. The analysis results and prescriptions were also evaluated using the medical charts. The severity of OSAS was classified as mild, moderate, and severe based on the abnormal respiratory events as assessed by the respiratory disturbance index (RDI).


There was no statistically significant relationship between the OSAS severity and the rate of cardiovascular diseases or hyperlipidemia. However, the incidence of DM increased, as the severity of OSAS increased.


Obstructive sleep apnea syndrome is an important public health problem and our study results suggest that it plays a role both in the development and progression of many diseases. The presence of symptoms related to the systemic diseases commonly occurring in association with OSAS necessitates further clinical and laboratory investigation.


OSAS Comorbidities Diabetes mellitus Cardiovascular 


  1. 1.
    Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients: mortality. Chest. 1988;94(12):1200–4.CrossRefGoogle Scholar
  2. 2.
    Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993;328:1230–5.CrossRefGoogle Scholar
  3. 3.
    The Report of an American Academy of Sleep MedicineTask Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667–89.CrossRefGoogle Scholar
  4. 4.
    Lavie L. Obstructive sleep apnea syndrome—an oxidative stress disorder. Sleep Med Rev. 2003;7:35–51.CrossRefGoogle Scholar
  5. 5.
    Karadağ M, Kolsuz M. Cardiovascular outcomes of sleep respiratory disorders. In: Özlü T, Metintaş M, Karadağ M, Kaya A, editors. Respiratory system diseases. 1st ed. İstanbul: İstanbul Medikal Yayıncılık; 2010. p. 2175–88.Google Scholar
  6. 6.
    Chugh DK, Dinges DF. Mechanisms of sleepness in obstructive sleep apnea. In: Pack AL, editor. Sleep apnea: pathogenesis, diagnosis and treatment, lung biology in health and disease. New York: Marcel Dekker; 2002. p. 265–85.CrossRefGoogle Scholar
  7. 7.
    Findley L, Unverzagt M, Guchu R, et al. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest. 1995;108:619–24.CrossRefGoogle Scholar
  8. 8.
    Rodenstein DO. Sleep apnea syndrome: the health economics point of view. Monaldi Arch Chest Dis. 2000;55:404–10.PubMedGoogle Scholar
  9. 9.
    Yılmaz A, Çiledağ A. Systemic disease association in obstructive sleep apnea syndrome. J Turkish Sleep Med. 2015;3:65–8.CrossRefGoogle Scholar
  10. 10.
    Hoş ÜD, et al. Concomitant endocrine and metabolic diseases in obstructive sleep apnea syndrome: clinical and polysomnographic retrospective analysis. JTSM. 2014;1(Special Issue 1).Google Scholar
  11. 11.
    Karakoç Ö, et al. Obstructive sleep apnea and chronic diseases. Ear Nose Throat Forum. 2008;7:15–20.Google Scholar
  12. 12.
    Peled N, Abinader EG, Pillar G, et al. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol. 1999;34:1744–9.CrossRefGoogle Scholar
  13. 13.
    Franklin KA, Nilsson JB, Sahlin C, Naslund U. Sleep apnea in nocturnal angina. Lancet. 1995;345:1085–7.CrossRefGoogle Scholar
  14. 14.
    Otsuka K. Hypertension and altered cardiovascular variability associated with obstructive sleep apnea. Nippon Rinsho. 2000;58:1711–6.PubMedGoogle Scholar
  15. 15.
    Naughton MT. The link between obstructive sleep apnea and heart failure: underappreciated opportunity for treatment. Curr Cardiol Rep. 2005;7:211–5.CrossRefGoogle Scholar
  16. 16.
    Flemons WW, Remmers JE, Gillis AM. Sleep apnea and cardiac arrhythmias. Is there a relationship? Am Rev Respir Dis. 1993;148:618–21.CrossRefGoogle Scholar
  17. 17.
    Hoffstein V, Mateika S. Cardiac arrhythmias, snoring and sleep apnea. Chest. 1994;106:466–71.CrossRefGoogle Scholar
  18. 18.
    Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health study. Am J Respir Crit Care Med. 2001;163:19–25.CrossRefGoogle Scholar
  19. 19.
    Dursunoglu D, Dursunoglu N, Evrengül H, et al. Impact of obstructive sleep apnea on left ventricular mass and global function. Eur Respir J. 2005;26:283–8.CrossRefGoogle Scholar
  20. 20.
    De Olazabel JR, Miller MJ, Cook WR, et al. Disordered breathing and hypoxia during sleep in coronary artery disease. Chest. 1982;82:548–52.CrossRefGoogle Scholar
  21. 21.
    Schafer H, Koehler U, Ewig S, et al. Obstructive sleep apnea as a risk marker in coronary artery disease. Cardiology. 1999;92:79–84.CrossRefGoogle Scholar
  22. 22.
    Calhoun DA. Obstructive sleep apnea and hypertension. Curr Hypertens Rep. 2010;12:189–95.CrossRefGoogle Scholar
  23. 23.
    Friedman O, Bradley TD, Ruttanaumpawan P, Logan AG. Independent association of drug-resistant hypertension to reduced sleep duration and efficiency. Am J Hypertens. 2010;23:174–9.CrossRefGoogle Scholar
  24. 24.
    Knutson KL, Van Cauter E, Rathouz PJ, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009;169:1055–61.CrossRefGoogle Scholar
  25. 25.
    Wolf J, Hering D, Narkiewicz K. Nondipping pattern of hypertension and obstructive sleep apnea syndrome. Hypertens Res. 2010;33:867–71.CrossRefGoogle Scholar
  26. 26.
    Cioffi G, Russo TE, Stefenelli C, et al. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens. 2010;28:1074–82.CrossRefGoogle Scholar
  27. 27.
    Patel SR, Ayas NT, Malhotra MR, et al. A prospective study of sleep duration and mortality risk in women. Sleep. 2004;27:440–4.CrossRefGoogle Scholar
  28. 28.
    Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med. 2009;6:e1000132.CrossRefGoogle Scholar
  29. 29.
    Kuhlmann U, Becker HF, Birkhahn M, et al. Sleep-apnea in patients with end-stage renal disease and objective results. Clin Nephrol. 2000;53:460–6.PubMedGoogle Scholar
  30. 30.
    Shayamsunder AK, Patel SS, Jain V, et al. Sleepiness, sleeplessness, and pain in end-stage renal disease: distressing symptoms for patients. Semin Dial. 2005;18:109–18.CrossRefGoogle Scholar
  31. 31.
    Caples SM, Gami AS, Somers VK. Obstructive sleep apnea. Ann Intern Med. 2005;142:187–97.CrossRefGoogle Scholar
  32. 32.
    Roux F, D’Ambrosio C, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med. 2000;108:396–402.CrossRefGoogle Scholar
  33. 33.
    Garpestad E, Basner RC, Ringler J, et al. Phenylephrine-induced hypertension acutely decreases genioglossus EMG activity in awake humans. J Appl Physiol. 1992;72:110–5.CrossRefGoogle Scholar
  34. 34.
    Mayor AH, Schwartz AR, Rowley JA, et al. Effect of blood pressure changes on air flow dynamics in the upper airway of the decerebrate cat. Anesthesiology. 1996;84:128–34.CrossRefGoogle Scholar
  35. 35.
    Wasicko MJ, Giering RW, Knuth SL, Leiter JC. Hypoglossal and phrenic nerve responses to carotid baroreceptor stimulation. J Appl Physiol. 1993;75:1395–403.CrossRefGoogle Scholar
  36. 36.
    Lavie P, Herer P, Hoffstein V. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ. 2000;320:479–82.CrossRefGoogle Scholar
  37. 37.
    Punjabi NM, Shahar E, Redline S, et al. Sleep-disordered breathing, glucose intolerance and insülin resistance: the Sleep Heart Health study. Am J Epidemol. 2004;160:521–30.CrossRefGoogle Scholar
  38. 38.
    Reichmuth KJ, Austin D, Skatrud JB, et al. Association of sleep apnea and type 2 diabetes: a population-based study. Am J Respir Crit Care Med. 2005;172:1590–5.CrossRefGoogle Scholar
  39. 39.
    Teramoto S, Ogha E, Matsui H, et al. Obstructive sleep apnea syndrome may be a significant cause of gastroesophageal reflux disease in older people. J Am Geriatr Soc. 1999;47:1273–4.CrossRefGoogle Scholar
  40. 40.
    Teramoto S, Sudo E, Ogha E, et al. Impaired swallowing reflex in patients with obstructive sleep apnea syndrome. Chest. 1999;116:17–21.CrossRefGoogle Scholar
  41. 41.
    Teramoto S, Ouchi Y. A possible pathologic link between chronic cough and sleep apnea syndrome through gastroesophageal reflux disease in older people (letter). Chest. 2000;117:1215–6.CrossRefGoogle Scholar
  42. 42.
    Köktürk O, et al. Prevalence of obstructive sleep apnea syndrome in cases with habitual snoring. Tuberk Toraks. 1996;44:7–11.Google Scholar
  43. 43.
    Chaouat A, Weitzenblum E, Krieger J, Ifoundza T, Oswald M, Kessler R. Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med. 1995;151:82–6.CrossRefGoogle Scholar
  44. 44.
    Miller CM, Husain AM. Should women with obstructive sleep apnea syndrome be screened for hypothyroidism? Sleep Breath. 2003;7:185–8.CrossRefGoogle Scholar
  45. 45.
    Özışık NÇ, Yurteri G, Tüzün B, Öztürk Ö, Oruç Ö. Obstrüktif uyku apne sendromu olgularında hipotiroidi taraması yapılmalı mı? S.D.Ü.Tıp Fak Derg. 2008;15:18–22.Google Scholar
  46. 46.
    Zimmerman M, McGlinchey JB, Young D, Chelminski I. Diagnosing major depressive disorder I: a psychometric evaluation of the DSM-IV symptom criteria. J Nerv Ment Dis. 2006;194:158–63.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Faculty of Medicine Chest Diseases DepartmentCanakkale 18 Mart UniversityÇanakkaleTurkey

Personalised recommendations